Announcements Trials
Browse Landscape

Phase

Phase 2/3 2Phase 2 2Phase 3 1

Status

Unknown 5Recruiting 5Active not recruiting 3Terminated 2Not yet recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Esophageal Neoplasms 8Esophageal Squamous Cell Carcinoma 5Pathologic Complete Response 1Obesity 1Deglutition Disorders 1Carcinoma, Squamous Cell 1Adenocarcinoma 1

Interventions

Cisplatin 28Paclitaxel 19Radiotherapy 17Fluorouracil 13Drug Therapy 12camrelizumab 10toripalimab 8Carboplatin 8Radiation 7Capecitabine 7Radiotherapy, Intensity-Modulated 6sintilimab 5S 1 (combination) 5Esophagectomy 5tislelizumab 4nimotuzumab 4apatinib 4anlotinib 4Irinotecan 4Cetuximab 4Afatinib 4pembrolizumab 3durvalumab 3Vinorelbine 3Positron Emission Tomography Computed Tomography 3Oxaliplatin 3Nivolumab 3Immune Checkpoint Inhibitors 3Docetaxel 3Albumin-Bound Paclitaxel 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × Esophageal Squamous Cell Carcinoma × Esophagectomy × Clear all
NCT02465736 2024-01-16

Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)

Sun Yat-sen University

Phase 3 Unknown
610 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT05596890 2022-11-28

PICCRT

Guangdong Provincial People's Hospital

Phase 2 Unknown
50 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Deglutition Disorders

NCT05213312 2022-06-15

Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC

Shanghai Zhongshan Hospital

Phase 2/3 Unknown
90 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT03623737 2022-06-07

Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCC

National Taiwan University Hospital

Phase 2/3 Unknown
248 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT04006041 2019-12-26

Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Sun Yat-sen University

Phase 2 Unknown
44 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon âš¡